APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tuberculosis Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Tuberculosis Vaccine Market Analysis and Forecast 2026-2032

Report ID 174043560229 December 2025193 pages

Choose your research edition.

Industry ResearchTuberculosis Vaccine Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Tuberculosis Vaccine Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Tuberculosis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tuberculosis Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Tuberculosis Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Tuberculosis Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Tuberculosis Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Tuberculosis Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Tuberculosis Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Tuberculosis Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Tuberculosis Vaccine include AJ Vaccines, Ataulpho de Paiva, BioFarma, Biomed Lublin, GreenSignal Bio Pharma, IVAC, Japan BCG Lab, Microgen and Queen Saovabha Mem. Inst, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Tuberculosis Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Tuberculosis Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Tuberculosis Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tuberculosis Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tuberculosis Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Tuberculosis Vaccine sales, projected growth trends, production technology, application and end-user industry.

Tuberculosis Vaccine Segment by Company

AJ Vaccines

Ataulpho de Paiva

BioFarma

Biomed Lublin

GreenSignal Bio Pharma

IVAC

Japan BCG Lab

Microgen

Queen Saovabha Mem. Inst

Serum Institute of India

Taj Pharmaceuticals

Merck

China National Biotec

Tuberculosis Vaccine Segment by Type

Immune Vaccine

Therapy Vaccine

Tuberculosis Vaccine Segment by Application

Self-Procurement

UNICEF

Other

Tuberculosis Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Tuberculosis Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Tuberculosis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tuberculosis Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tuberculosis Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Immune Vaccine Major Manufacturers Table 3. Therapy Vaccine Major Manufacturers Table 4. Global Tuberculosis Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Self-Procurement Major Manufacturers Table 6. UNICEF Major Manufacturers Table 7. Other Major Manufacturers Table 8. Tuberculosis Vaccine Industry Trends Table 9. Tuberculosis Vaccine Industry Drivers Table 10. Tuberculosis Vaccine Industry Opportunities and Challenges Table 11. Tuberculosis Vaccine Industry Restraints Table 12. Global Tuberculosis Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Tuberculosis Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Tuberculosis Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Tuberculosis Vaccine Revenue Market Share by Region (2021-2026) Table 16. Global Tuberculosis Vaccine Revenue Market Share by Region (2027-2032) Table 17. Global Tuberculosis Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Tuberculosis Vaccine Sales by Region (2021-2026) & (K Units) Table 19. Global Tuberculosis Vaccine Sales by Region (2027-2032) & (K Units) Table 20. Global Tuberculosis Vaccine Sales Market Share by Region (2021-2026) Table 21. Global Tuberculosis Vaccine Sales Market Share by Region (2027-2032) Table 22. Global Tuberculosis Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Tuberculosis Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Tuberculosis Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Tuberculosis Vaccine Sales Market Share by Manufacturers (2021-2026) Table 26. Global Tuberculosis Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Tuberculosis Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Tuberculosis Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Tuberculosis Vaccine Manufacturers, Product Type & Application Table 30. Global Tuberculosis Vaccine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Tuberculosis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Tuberculosis Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Tuberculosis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Tuberculosis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Tuberculosis Vaccine Revenue Market Share by Type (2021-2026) Table 37. Global Tuberculosis Vaccine Revenue Market Share by Type (2027-2032) Table 38. Global Tuberculosis Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Tuberculosis Vaccine Sales by Type (2021-2026) & (K Units) Table 40. Global Tuberculosis Vaccine Sales by Type (2027-2032) & (K Units) Table 41. Global Tuberculosis Vaccine Sales Market Share by Type (2021-2026) Table 42. Global Tuberculosis Vaccine Sales Market Share by Type (2027-2032) Table 43. Global Tuberculosis Vaccine Price by Type (2021-2026) & (US$/Unit) Table 44. Global Tuberculosis Vaccine Price by Type (2027-2032) & (US$/Unit) Table 45. Global Tuberculosis Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Tuberculosis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Tuberculosis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Tuberculosis Vaccine Revenue Market Share by Application (2021-2026) Table 49. Global Tuberculosis Vaccine Revenue Market Share by Application (2027-2032) Table 50. Global Tuberculosis Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Tuberculosis Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Tuberculosis Vaccine Sales by Application (2027-2032) & (K Units) Table 53. Global Tuberculosis Vaccine Sales Market Share by Application (2021-2026) Table 54. Global Tuberculosis Vaccine Sales Market Share by Application (2027-2032) Table 55. Global Tuberculosis Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Tuberculosis Vaccine Price by Application (2027-2032) & (US$/Unit) Table 57. AJ Vaccines Company Information Table 58. AJ Vaccines Business Overview Table 59. AJ Vaccines Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. AJ Vaccines Tuberculosis Vaccine Product Portfolio Table 61. AJ Vaccines Recent Development Table 62. Ataulpho de Paiva Company Information Table 63. Ataulpho de Paiva Business Overview Table 64. Ataulpho de Paiva Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Ataulpho de Paiva Tuberculosis Vaccine Product Portfolio Table 66. Ataulpho de Paiva Recent Development Table 67. BioFarma Company Information Table 68. BioFarma Business Overview Table 69. BioFarma Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. BioFarma Tuberculosis Vaccine Product Portfolio Table 71. BioFarma Recent Development Table 72. Biomed Lublin Company Information Table 73. Biomed Lublin Business Overview Table 74. Biomed Lublin Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Biomed Lublin Tuberculosis Vaccine Product Portfolio Table 76. Biomed Lublin Recent Development Table 77. GreenSignal Bio Pharma Company Information Table 78. GreenSignal Bio Pharma Business Overview Table 79. GreenSignal Bio Pharma Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. GreenSignal Bio Pharma Tuberculosis Vaccine Product Portfolio Table 81. GreenSignal Bio Pharma Recent Development Table 82. IVAC Company Information Table 83. IVAC Business Overview Table 84. IVAC Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. IVAC Tuberculosis Vaccine Product Portfolio Table 86. IVAC Recent Development Table 87. Japan BCG Lab Company Information Table 88. Japan BCG Lab Business Overview Table 89. Japan BCG Lab Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Japan BCG Lab Tuberculosis Vaccine Product Portfolio Table 91. Japan BCG Lab Recent Development Table 92. Microgen Company Information Table 93. Microgen Business Overview Table 94. Microgen Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Microgen Tuberculosis Vaccine Product Portfolio Table 96. Microgen Recent Development Table 97. Queen Saovabha Mem. Inst Company Information Table 98. Queen Saovabha Mem. Inst Business Overview Table 99. Queen Saovabha Mem. Inst Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Queen Saovabha Mem. Inst Tuberculosis Vaccine Product Portfolio Table 101. Queen Saovabha Mem. Inst Recent Development Table 102. Serum Institute of India Company Information Table 103. Serum Institute of India Business Overview Table 104. Serum Institute of India Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Serum Institute of India Tuberculosis Vaccine Product Portfolio Table 106. Serum Institute of India Recent Development Table 107. Taj Pharmaceuticals Company Information Table 108. Taj Pharmaceuticals Business Overview Table 109. Taj Pharmaceuticals Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Taj Pharmaceuticals Tuberculosis Vaccine Product Portfolio Table 111. Taj Pharmaceuticals Recent Development Table 112. Merck Company Information Table 113. Merck Business Overview Table 114. Merck Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Merck Tuberculosis Vaccine Product Portfolio Table 116. Merck Recent Development Table 117. China National Biotec Company Information Table 118. China National Biotec Business Overview Table 119. China National Biotec Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. China National Biotec Tuberculosis Vaccine Product Portfolio Table 121. China National Biotec Recent Development Table 122. North America Tuberculosis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Tuberculosis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Tuberculosis Vaccine Sales by Type (2021-2026) & (K Units) Table 125. North America Tuberculosis Vaccine Sales by Type (2027-2032) & (K Units) Table 126. North America Tuberculosis Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 127. North America Tuberculosis Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 128. North America Tuberculosis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 129. North America Tuberculosis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 130. North America Tuberculosis Vaccine Sales by Application (2021-2026) & (K Units) Table 131. North America Tuberculosis Vaccine Sales by Application (2027-2032) & (K Units) Table 132. North America Tuberculosis Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 133. North America Tuberculosis Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 134. North America Tuberculosis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Tuberculosis Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. North America Tuberculosis Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. North America Tuberculosis Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 138. North America Tuberculosis Vaccine Sales by Country (2021-2026) & (K Units) Table 139. North America Tuberculosis Vaccine Sales by Country (2027-2032) & (K Units) Table 140. North America Tuberculosis Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 141. North America Tuberculosis Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 142. United States Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 143. Canada Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 144. Europe Tuberculosis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 145. Europe Tuberculosis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 146. Europe Tuberculosis Vaccine Sales by Type (2021-2026) & (K Units) Table 147. Europe Tuberculosis Vaccine Sales by Type (2027-2032) & (K Units) Table 148. Europe Tuberculosis Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 149. Europe Tuberculosis Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 150. Europe Tuberculosis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 151. Europe Tuberculosis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 152. Europe Tuberculosis Vaccine Sales by Application (2021-2026) & (K Units) Table 153. Europe Tuberculosis Vaccine Sales by Application (2027-2032) & (K Units) Table 154. Europe Tuberculosis Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 155. Europe Tuberculosis Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 156. Europe Tuberculosis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Europe Tuberculosis Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. Europe Tuberculosis Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. Europe Tuberculosis Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 160. Europe Tuberculosis Vaccine Sales by Country (2021-2026) & (K Units) Table 161. Europe Tuberculosis Vaccine Sales by Country (2027-2032) & (K Units) Table 162. Europe Tuberculosis Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 163. Europe Tuberculosis Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 164. Germany Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 165. France Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 166. U.K. Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 167. Italy Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 168. Netherlands Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 169. Nordic Countries Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 170. China Tuberculosis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 171. China Tuberculosis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 172. China Tuberculosis Vaccine Sales by Type (2021-2026) & (K Units) Table 173. China Tuberculosis Vaccine Sales by Type (2027-2032) & (K Units) Table 174. China Tuberculosis Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 175. China Tuberculosis Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 176. China Tuberculosis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 177. China Tuberculosis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 178. China Tuberculosis Vaccine Sales by Application (2021-2026) & (K Units) Table 179. China Tuberculosis Vaccine Sales by Application (2027-2032) & (K Units) Table 180. China Tuberculosis Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 181. China Tuberculosis Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Asia Tuberculosis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Tuberculosis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Tuberculosis Vaccine Sales by Type (2021-2026) & (K Units) Table 185. Asia Tuberculosis Vaccine Sales by Type (2027-2032) & (K Units) Table 186. Asia Tuberculosis Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 187. Asia Tuberculosis Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 188. Asia Tuberculosis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Tuberculosis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Tuberculosis Vaccine Sales by Application (2021-2026) & (K Units) Table 191. Asia Tuberculosis Vaccine Sales by Application (2027-2032) & (K Units) Table 192. Asia Tuberculosis Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 193. Asia Tuberculosis Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 194. Asia Tuberculosis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Tuberculosis Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Tuberculosis Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Tuberculosis Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 198. Asia Tuberculosis Vaccine Sales by Country (2021-2026) & (K Units) Table 199. Asia Tuberculosis Vaccine Sales by Country (2027-2032) & (K Units) Table 200. Asia Tuberculosis Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 201. Asia Tuberculosis Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Japan Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 203. South Korea Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 204. India Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 205. Australia Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 206. China Taiwan Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Tuberculosis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Tuberculosis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Tuberculosis Vaccine Sales by Type (2021-2026) & (K Units) Table 211. SAMEA Tuberculosis Vaccine Sales by Type (2027-2032) & (K Units) Table 212. SAMEA Tuberculosis Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 213. SAMEA Tuberculosis Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 214. SAMEA Tuberculosis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Tuberculosis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Tuberculosis Vaccine Sales by Application (2021-2026) & (K Units) Table 217. SAMEA Tuberculosis Vaccine Sales by Application (2027-2032) & (K Units) Table 218. SAMEA Tuberculosis Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 219. SAMEA Tuberculosis Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 220. SAMEA Tuberculosis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Tuberculosis Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Tuberculosis Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Tuberculosis Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 224. SAMEA Tuberculosis Vaccine Sales by Country (2021-2026) & (K Units) Table 225. SAMEA Tuberculosis Vaccine Sales by Country (2027-2032) & (K Units) Table 226. SAMEA Tuberculosis Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 227. SAMEA Tuberculosis Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 228. Brazil Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 229. Argentina Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 230. Chile Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 231. Colombia Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 232. Peru Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 234. Israel Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 235. UAE Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 236. Turkey Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 237. Iran Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 238. Egypt Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Tuberculosis Vaccine Distributors List Table 242. Tuberculosis Vaccine Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Tuberculosis Vaccine Image Figure 2. Global Tuberculosis Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tuberculosis Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Immune Vaccine Image Figure 5. Therapy Vaccine Image Figure 6. Global Tuberculosis Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Tuberculosis Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Self-Procurement Image Figure 9. UNICEF Image Figure 10. Other Image Figure 11. Global Tuberculosis Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Figure 13. Global Tuberculosis Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Tuberculosis Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Tuberculosis Vaccine Revenue Market Share by Region (2021-2032) Figure 16. Global Tuberculosis Vaccine Sales (2021-2032) & (K Units) Figure 17. Global Tuberculosis Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Tuberculosis Vaccine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Tuberculosis Vaccine Sales YoY (2021-2032) & (K Units) Figure 20. Europe Tuberculosis Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. China Tuberculosis Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Tuberculosis Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Tuberculosis Vaccine Sales YoY (2021-2032) & (K Units) Figure 24. Global Tuberculosis Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Tuberculosis Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Tuberculosis Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Tuberculosis Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Tuberculosis Vaccine Revenue Market Share by Type (2021-2032) Figure 30. Global Tuberculosis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Tuberculosis Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Tuberculosis Vaccine Sales Market Share by Type (2021-2032) Figure 33. Global Tuberculosis Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Tuberculosis Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Tuberculosis Vaccine Revenue Market Share by Application (2021-2032) Figure 36. Global Tuberculosis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Tuberculosis Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Tuberculosis Vaccine Sales Market Share by Application (2021-2032) Figure 39. North America Tuberculosis Vaccine Revenue Share by Type (2021-2032) Figure 40. North America Tuberculosis Vaccine Sales Share by Type (2021-2032) Figure 41. North America Tuberculosis Vaccine Revenue Share by Application (2021-2032) Figure 42. North America Tuberculosis Vaccine Sales Share by Application (2021-2032) Figure 43. North America Tuberculosis Vaccine Revenue Share by Country (2021-2032) Figure 44. North America Tuberculosis Vaccine Sales Share by Country (2021-2032) Figure 45. Europe Tuberculosis Vaccine Revenue Share by Type (2021-2032) Figure 46. Europe Tuberculosis Vaccine Sales Share by Type (2021-2032) Figure 47. Europe Tuberculosis Vaccine Revenue Share by Application (2021-2032) Figure 48. Europe Tuberculosis Vaccine Sales Share by Application (2021-2032) Figure 49. Europe Tuberculosis Vaccine Revenue Share by Country (2021-2032) Figure 50. Europe Tuberculosis Vaccine Sales Share by Country (2021-2032) Figure 51. China Tuberculosis Vaccine Revenue Share by Type (2021-2032) Figure 52. China Tuberculosis Vaccine Sales Share by Type (2021-2032) Figure 53. China Tuberculosis Vaccine Revenue Share by Application (2021-2032) Figure 54. China Tuberculosis Vaccine Sales Share by Application (2021-2032) Figure 55. Asia Tuberculosis Vaccine Revenue Share by Type (2021-2032) Figure 56. Asia Tuberculosis Vaccine Sales Share by Type (2021-2032) Figure 57. Asia Tuberculosis Vaccine Revenue Share by Application (2021-2032) Figure 58. Asia Tuberculosis Vaccine Sales Share by Application (2021-2032) Figure 59. Asia Tuberculosis Vaccine Revenue Share by Country (2021-2032) Figure 60. Asia Tuberculosis Vaccine Sales Share by Country (2021-2032) Figure 61. SAMEA Tuberculosis Vaccine Revenue Share by Type (2021-2032) Figure 62. SAMEA Tuberculosis Vaccine Sales Share by Type (2021-2032) Figure 63. SAMEA Tuberculosis Vaccine Revenue Share by Application (2021-2032) Figure 64. SAMEA Tuberculosis Vaccine Sales Share by Application (2021-2032) Figure 65. SAMEA Tuberculosis Vaccine Revenue Share by Country (2021-2032) Figure 66. SAMEA Tuberculosis Vaccine Sales Share by Country (2021-2032) Figure 67. Tuberculosis Vaccine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Tuberculosis Vaccine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Immune Vaccine
  • Therapy Vaccine
Applications
  • Self-Procurement
  • UNICEF
  • Other
Companies covered
  • AJ Vaccines
  • Ataulpho de Paiva
  • BioFarma
  • Biomed Lublin
  • GreenSignal Bio Pharma
  • IVAC
  • Japan BCG Lab
  • Microgen
  • Queen Saovabha Mem. Inst
  • Serum Institute of India
  • Taj Pharmaceuticals
  • Merck
  • China National Biotec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Tuberculosis Vaccine Market by Type
  3. 1.2.1 Global Tuberculosis Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Immune Vaccine
  5. 1.2.3 Therapy Vaccine
  6. 1.3 Tuberculosis Vaccine Market by Application
  7. 1.3.1 Global Tuberculosis Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Self-Procurement
  9. 1.3.3 UNICEF
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Tuberculosis Vaccine Market Dynamics
  1. 2.1 Tuberculosis Vaccine Industry Trends
  2. 2.2 Tuberculosis Vaccine Industry Drivers
  3. 2.3 Tuberculosis Vaccine Industry Opportunities and Challenges
  4. 2.4 Tuberculosis Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Tuberculosis Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Tuberculosis Vaccine Revenue by Region
  3. 3.2.1 Global Tuberculosis Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Tuberculosis Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Tuberculosis Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Tuberculosis Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Tuberculosis Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Tuberculosis Vaccine Sales by Region
  9. 3.4.1 Global Tuberculosis Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Tuberculosis Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Tuberculosis Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Tuberculosis Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Tuberculosis Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Tuberculosis Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Tuberculosis Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Tuberculosis Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Tuberculosis Vaccine Sales by Manufacturers
  6. 4.2.1 Global Tuberculosis Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Tuberculosis Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Tuberculosis Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Tuberculosis Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Tuberculosis Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Tuberculosis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Tuberculosis Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Tuberculosis Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Tuberculosis Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Tuberculosis Vaccine Tier 1, Tier 2, and Tier 3
5 Tuberculosis Vaccine Market by Type
  1. 5.1 Global Tuberculosis Vaccine Revenue by Type
  2. 5.1.1 Global Tuberculosis Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Tuberculosis Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Tuberculosis Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Tuberculosis Vaccine Sales by Type
  6. 5.2.1 Global Tuberculosis Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tuberculosis Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Tuberculosis Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Tuberculosis Vaccine Price by Type
6 Tuberculosis Vaccine Market by Application
  1. 6.1 Global Tuberculosis Vaccine Revenue by Application
  2. 6.1.1 Global Tuberculosis Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Tuberculosis Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Tuberculosis Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Tuberculosis Vaccine Sales by Application
  6. 6.2.1 Global Tuberculosis Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Tuberculosis Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Tuberculosis Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Tuberculosis Vaccine Price by Application
7 Company Profiles
  1. 7.1 AJ Vaccines
  2. 7.1.1 AJ Vaccines Company Information
  3. 7.1.2 AJ Vaccines Business Overview
  4. 7.1.3 AJ Vaccines Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AJ Vaccines Tuberculosis Vaccine Product Portfolio
  6. 7.1.5 AJ Vaccines Recent Developments
  7. 7.2 Ataulpho de Paiva
  8. 7.2.1 Ataulpho de Paiva Company Information
  9. 7.2.2 Ataulpho de Paiva Business Overview
  10. 7.2.3 Ataulpho de Paiva Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Ataulpho de Paiva Tuberculosis Vaccine Product Portfolio
  12. 7.2.5 Ataulpho de Paiva Recent Developments
  13. 7.3 BioFarma
  14. 7.3.1 BioFarma Company Information
  15. 7.3.2 BioFarma Business Overview
  16. 7.3.3 BioFarma Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 BioFarma Tuberculosis Vaccine Product Portfolio
  18. 7.3.5 BioFarma Recent Developments
  19. 7.4 Biomed Lublin
  20. 7.4.1 Biomed Lublin Company Information
  21. 7.4.2 Biomed Lublin Business Overview
  22. 7.4.3 Biomed Lublin Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Biomed Lublin Tuberculosis Vaccine Product Portfolio
  24. 7.4.5 Biomed Lublin Recent Developments
  25. 7.5 GreenSignal Bio Pharma
  26. 7.5.1 GreenSignal Bio Pharma Company Information
  27. 7.5.2 GreenSignal Bio Pharma Business Overview
  28. 7.5.3 GreenSignal Bio Pharma Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 GreenSignal Bio Pharma Tuberculosis Vaccine Product Portfolio
  30. 7.5.5 GreenSignal Bio Pharma Recent Developments
  31. 7.6 IVAC
  32. 7.6.1 IVAC Company Information
  33. 7.6.2 IVAC Business Overview
  34. 7.6.3 IVAC Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 IVAC Tuberculosis Vaccine Product Portfolio
  36. 7.6.5 IVAC Recent Developments
  37. 7.7 Japan BCG Lab
  38. 7.7.1 Japan BCG Lab Company Information
  39. 7.7.2 Japan BCG Lab Business Overview
  40. 7.7.3 Japan BCG Lab Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Japan BCG Lab Tuberculosis Vaccine Product Portfolio
  42. 7.7.5 Japan BCG Lab Recent Developments
  43. 7.8 Microgen
  44. 7.8.1 Microgen Company Information
  45. 7.8.2 Microgen Business Overview
  46. 7.8.3 Microgen Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Microgen Tuberculosis Vaccine Product Portfolio
  48. 7.8.5 Microgen Recent Developments
  49. 7.9 Queen Saovabha Mem. Inst
  50. 7.9.1 Queen Saovabha Mem. Inst Company Information
  51. 7.9.2 Queen Saovabha Mem. Inst Business Overview
  52. 7.9.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Product Portfolio
  54. 7.9.5 Queen Saovabha Mem. Inst Recent Developments
  55. 7.10 Serum Institute of India
  56. 7.10.1 Serum Institute of India Company Information
  57. 7.10.2 Serum Institute of India Business Overview
  58. 7.10.3 Serum Institute of India Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Serum Institute of India Tuberculosis Vaccine Product Portfolio
  60. 7.10.5 Serum Institute of India Recent Developments
  61. 7.11 Taj Pharmaceuticals
  62. 7.11.1 Taj Pharmaceuticals Company Information
  63. 7.11.2 Taj Pharmaceuticals Business Overview
  64. 7.11.3 Taj Pharmaceuticals Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Taj Pharmaceuticals Tuberculosis Vaccine Product Portfolio
  66. 7.11.5 Taj Pharmaceuticals Recent Developments
  67. 7.12 Merck
  68. 7.12.1 Merck Company Information
  69. 7.12.2 Merck Business Overview
  70. 7.12.3 Merck Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Merck Tuberculosis Vaccine Product Portfolio
  72. 7.12.5 Merck Recent Developments
  73. 7.13 China National Biotec
  74. 7.13.1 China National Biotec Company Information
  75. 7.13.2 China National Biotec Business Overview
  76. 7.13.3 China National Biotec Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 China National Biotec Tuberculosis Vaccine Product Portfolio
  78. 7.13.5 China National Biotec Recent Developments
8 North America
  1. 8.1 North America Tuberculosis Vaccine Market Size by Type
  2. 8.1.1 North America Tuberculosis Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Tuberculosis Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Tuberculosis Vaccine Price by Type (2021-2032)
  5. 8.2 North America Tuberculosis Vaccine Market Size by Application
  6. 8.2.1 North America Tuberculosis Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Tuberculosis Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Tuberculosis Vaccine Price by Application (2021-2032)
  9. 8.3 North America Tuberculosis Vaccine Market Size by Country
  10. 8.3.1 North America Tuberculosis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Tuberculosis Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Tuberculosis Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Tuberculosis Vaccine Market Size by Type
  2. 9.1.1 Europe Tuberculosis Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Tuberculosis Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Tuberculosis Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Tuberculosis Vaccine Market Size by Application
  6. 9.2.1 Europe Tuberculosis Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Tuberculosis Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Tuberculosis Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Tuberculosis Vaccine Market Size by Country
  10. 9.3.1 Europe Tuberculosis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Tuberculosis Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Tuberculosis Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Tuberculosis Vaccine Market Size by Type
  2. 10.1.1 China Tuberculosis Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Tuberculosis Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Tuberculosis Vaccine Price by Type (2021-2032)
  5. 10.2 China Tuberculosis Vaccine Market Size by Application
  6. 10.2.1 China Tuberculosis Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Tuberculosis Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Tuberculosis Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Tuberculosis Vaccine Market Size by Type
  2. 11.1.1 Asia Tuberculosis Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Tuberculosis Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Tuberculosis Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Tuberculosis Vaccine Market Size by Application
  6. 11.2.1 Asia Tuberculosis Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Tuberculosis Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Tuberculosis Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Tuberculosis Vaccine Market Size by Country
  10. 11.3.1 Asia Tuberculosis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Tuberculosis Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Tuberculosis Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Tuberculosis Vaccine Market Size by Type
  2. 12.1.1 SAMEA Tuberculosis Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Tuberculosis Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Tuberculosis Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Tuberculosis Vaccine Market Size by Application
  6. 12.2.1 SAMEA Tuberculosis Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Tuberculosis Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Tuberculosis Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Tuberculosis Vaccine Market Size by Country
  10. 12.3.1 SAMEA Tuberculosis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Tuberculosis Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Tuberculosis Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Tuberculosis Vaccine Value Chain Analysis
  2. 13.1.1 Tuberculosis Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Tuberculosis Vaccine Production Mode & Process
  6. 13.2 Tuberculosis Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Tuberculosis Vaccine Distributors
  9. 13.2.3 Tuberculosis Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst